Literature DB >> 2905904

Evidence for dopaminergic co-transmission in dog mesenteric arterial vessels.

P Soares-da-Silva1.   

Abstract

1. The overflow of dopamine and noradrenaline (NA) from the main trunk of the dog mesenteric artery and its proximal branches during prolonged depolarization (120 min) by K+ (52 mM) was quantified by high performance liquid chromatography with electrochemical detection. 2. K+-induced depolarization resulted in release of both dopamine and NA. The amount of NA released from both blood vessels declined progressively throughout the experiment. In the main trunk the same pattern of release was observed for dopamine, whereas in the proximal branches the overflow of dopamine increased throughout the experiment. 3. The addition of phentolamine (0.2 microM) to the perifusion fluid increased the overflow of both amines. In the presence of sulpiride (1 microM) the overflow of dopamine and NA was found to be increased in the proximal branches, but not in the main trunk. The addition of phentolamine to sulpiride caused a further increase in amine overflow in proximal branches, but not in the main trunk. 4. The addition of alpha-methyl-p-tyrosine (50 microM) to the perifusion fluid caused a decrease in the amounts of dopamine and NA released from both preparations. In alpha-methyl-p-tyrosine-treated preparations phentolamine increased amine overflow to the same extent as in experiments without tyrosine hydroxylase inhibition. The increasing effect of sulpiride on the overflow of dopamine and NA from the proximal branches was completely abolished after alpha-methyl-p-tyrosine. 5. The results presented suggest that in the proximal branches of the dog mesenteric artery, dopamine beta-hydroxylase represents a rate limiting step in the synthesis of NA; dopamine, through activation of prejunctional dopamine receptors acts like a prejunctional co-transmitter in the control of transmitter release, but only newly-synthesized dopamine appears to be responsible for this effect.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 2905904      PMCID: PMC1854135          DOI: 10.1111/j.1476-5381.1988.tb16567.x

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  18 in total

Review 1.  Neuronal dopamine receptors on autonomic ganglia and sympathetic nerves and dopamine receptors in the gastrointestinal system.

Authors:  J L Willems; W A Buylaert; R A Lefebvre; M G Bogaert
Journal:  Pharmacol Rev       Date:  1985-06       Impact factor: 25.468

2.  A comparison between the pattern of dopamine and noradrenaline release from sympathetic neurones of the dog mesenteric artery.

Authors:  P Soares-da-Silva
Journal:  Br J Pharmacol       Date:  1987-01       Impact factor: 8.739

3.  Evidence for a non-precursor dopamine pool in noradrenergic neurones of the dog mesenteric artery.

Authors:  P Soares-da-Silva
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1986-07       Impact factor: 3.000

4.  Pharmacology of fusaric acid in man.

Authors:  R J Matta; G F Wooten
Journal:  Clin Pharmacol Ther       Date:  1973 Jul-Aug       Impact factor: 6.875

Review 5.  Presynaptic alpha-autoreceptors.

Authors:  K Starke
Journal:  Rev Physiol Biochem Pharmacol       Date:  1987       Impact factor: 5.545

6.  Vesicular storage of 3,4-dihydroxyphenylethylamine and noradrenaline in terminal sympathetic nerves of dog spleen and kidney.

Authors:  B D Muller; C Bell
Journal:  J Neurochem       Date:  1986-11       Impact factor: 5.372

7.  Effects of 6-hydroxydopamine on dopamine and noradrenaline content in dog blood vessels and heart. Evidence for a noradrenaline-independent dopamine pool.

Authors:  P Soares-da-Silva; R Davidson
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1985-05       Impact factor: 3.000

8.  Biochemical and functional properties of large and small dense-core vesicles in sympathetic nerves of rat and ox vas deferens.

Authors:  B Neuman; C J Wiedermann; R Fischer-Colbrie; M Schober; G Sperk; H Winkler
Journal:  Neuroscience       Date:  1984-11       Impact factor: 3.590

9.  Dopamine released from nerve terminals activates prejunctional dopamine receptors in dog mesenteric arterial vessels.

Authors:  P Soares-da-Silva
Journal:  Br J Pharmacol       Date:  1987-07       Impact factor: 8.739

10.  Cardiovascular effects of a new potent dopamine beta-hydroxylase inhibitor in spontaneously hypertensive rats.

Authors:  E H Ohlstein; L I Kruse; M Ezekiel; S S Sherman; R Erickson; W E DeWolf; B A Berkowitz
Journal:  J Pharmacol Exp Ther       Date:  1987-05       Impact factor: 4.030

View more
  5 in total

1.  Facilitatory and inhibitory modulation by endogenous adenosine of noradrenaline release in the epididymal portion of rat vas deferens.

Authors:  J Gonçalves; G Queiroz
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1993-10       Impact factor: 3.000

2.  Inhibition by the putative potassium channel opener pinacidil of the electrically-evoked release of endogenous dopamine and noradrenaline in the rat vas deferens.

Authors:  P Soares-da-Silva; M H Fernandes
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1990-10       Impact factor: 3.000

3.  Purinoceptor modulation of noradrenaline release in rat tail artery: tonic modulation mediated by inhibitory P2Y- and facilitatory A2A-purinoceptors.

Authors:  J Gonçalves; G Queiroz
Journal:  Br J Pharmacol       Date:  1996-01       Impact factor: 8.739

4.  Electrically-evoked release of taurine in the rat vas deferens: evidence for a purinoceptor-mediated effect.

Authors:  G Queiroz; J Gonçalves; F Carvalho; P Vale
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1995-01       Impact factor: 3.000

5.  The effects of quinpirole and fenoldopam on the potassium-evoked overflow of endogenous dopamine and noradrenaline in dog mesenteric arteries.

Authors:  P Soares-da-Silva
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1990 Jan-Feb       Impact factor: 3.000

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.